Latest Period
Q1 2026
Security Snapshot
PRECISION BIOSCIENCES INC - Common Stock, $0.000005 par value per share (DTIL) Institutional Ownership
CUSIP: 74019P207
13F Institutional Holders and Ownership History from Q1 2024 to Q1 2026
Institutions Reporting
75
Shares (Excl. Options)
16,006,452
Price
$5.50
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, $0.000005 par value per share
- Symbol
- DTIL on Nasdaq
- Shares outstanding
- 25,804,443
- Reported price per share
- $8.20
- Price from insider filings
- $8.20
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 16,006,452
- Total reported value
- $88,056,671
- Portfolio coverage rank
- 0%
- Share change
- +724,662
- Value change
- +$4,555,838
- Number of holders
- 75
Security identity
Issuer context
Latest holder snapshot
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Key facts
- DTIL - PRECISION BIOSCIENCES INC - Common Stock, $0.000005 par value per share is tracked under CUSIP 74019P207.
- 75 institutions reported positions in Q1 2026.
- 9 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 67 to 75 between Q4 2025 and Q1 2026.
- Reported value moved from $62,794,720 to $88,056,671.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 75 institutions filings for Q1 2026.
Security key
74019P207
Latest holder period
Q1 2026
13F holders
75
13D/G owners
9
CIK / CUSIP context first
Open Q1 2026 holders
DTIL full holder history
PRECISION BIOSCIENCES INC SEC filings
PRECISION BIOSCIENCES INC company facts
PRECISION BIOSCIENCES INC insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 74019P207:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
9
Security
DTIL
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Octagon Capital Advisors LP | 10% | $9,570,073 | 2,328,485 | Octagon Capital Advisors LP | 31 Dec 2025 | |||
| Aberdeen Group plc | 8.9% | $8,896,588 | 2,138,603 | Aberdeen Group plc | 31 Dec 2025 | |||
| Empery Asset Management, LP | 7.6% | -24% | $10,828,834 | -$1,808,961 | 1,968,879 | -14% | Empery Asset Management, LP | 31 Mar 2026 |
| Bleichroeder LP | 8.2% | -15% | $7,809,000 | +$3,390,750 | 1,900,000 | +77% | Bleichroeder LP | 31 Dec 2025 |
| Readout Capital, LP | 9.4% | +5.6% | $4,980,934 | +$829,645 | 1,119,311 | +20% | Matthew Smith | 30 Jun 2025 |
| Lynx1 Capital Management LP | 4.1% | -52% | $4,084,982 | -$200,087 | 993,913 | -4.7% | Lynx1 Capital Management LP | 31 Dec 2025 |
| NOVARTIS PHARMA AG | 3.7% | -34% | $1,840,435 | 413,581 | 0% | Novartis Pharma AG | 30 Jun 2025 | |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 3.7% | $2,165,312 | 406,250 | Highbridge Capital Management, LLC | 31 Mar 2025 | |||
| Weinstein Benjamin | 5.2% | $2,107,956 | 395,489 | Weinstein Benjamin | 18 Mar 2025 |
As of 31 Mar 2026, 75 institutional investors reported holding 16,006,452 shares of PRECISION BIOSCIENCES INC - Common Stock, $0.000005 par value per share (DTIL). This represents 62% of the company’s total 25,804,443 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
59%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Octagon Capital Advisors LP | 8.7% | 2,236,732 | +17% | 1.4% | $12,302,026 |
| Aberdeen Group plc | 8.6% | 2,230,178 | +4.3% | 0.02% | $12,265,979 |
| Empery Asset Management, LP | 7.6% | 1,968,879 | -10% | 13% | $10,828,835 |
| Bleichroeder LP | 6.4% | 1,662,500 | 0% | 1.6% | $9,143,750 |
| BOOTHBAY FUND MANAGEMENT, LLC | 4.1% | 1,066,050 | 0% | 0.14% | $5,863,275 |
| Driehaus Capital Management LLC | 3.9% | 995,371 | +26% | 0.04% | $5,474,541 |
| Lynx1 Capital Management LP | 3.8% | 985,113 | -0.89% | 0.86% | $5,418,122 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.5% | 910,740 | 0% | 0% | $5,009,070 |
| Affinity Asset Advisors, LLC | 2.3% | 597,946 | 0.19% | $3,288,703 | |
| MARSHALL WACE, LLP | 1.6% | 415,671 | +486% | 0% | $2,286,194 |
| TWO SIGMA INVESTMENTS, LP | 1.2% | 307,790 | +121% | 0% | $1,692,845 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.1% | 287,090 | +27% | 0% | $1,580,126 |
| RENAISSANCE TECHNOLOGIES LLC | 0.86% | 223,177 | -32% | 0% | $1,227,474 |
| BlackRock, Inc. | 0.77% | 199,761 | +19% | 0% | $1,098,687 |
| ArrowMark Colorado Holdings LLC | 0.69% | 179,140 | 0.03% | $985,270 | |
| VANGUARD FIDUCIARY TRUST CO | 0.6% | 155,626 | 0% | 0% | $855,943 |
| Alyeska Investment Group, L.P. | 0.54% | 138,825 | -83% | 0% | $763,538 |
| MORGAN STANLEY | 0.47% | 122,277 | +23% | 0% | $672,524 |
| CITADEL ADVISORS LLC | 0.45% | 115,952 | +636% | 0% | $637,736 |
| COMMONWEALTH EQUITY SERVICES, LLC | 0.44% | 112,671 | +21% | 0% | $619,690 |
| UBS Group AG | 0.31% | 81,133 | +32% | 0% | $446,232 |
| NORTHERN TRUST CORP | 0.29% | 76,069 | -12% | 0% | $418,380 |
| STATE STREET CORP | 0.28% | 72,942 | +24% | 0% | $401,181 |
| Quarry LP | 0.26% | 68,311 | 0% | 0.08% | $375,711 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.25% | 64,462 | -3.2% | 0% | $354,541 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
9
Latest
Q1 2026
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 16,006,452 | $88,056,671 | +$4,555,838 | $5.50 | 75 |
| 2025 Q4 | 15,096,207 | $62,794,720 | +$33,303,415 | $4.16 | 67 |
| 2025 Q3 | 4,649,562 | $25,664,758 | +$1,234,800 | $5.52 | 54 |
| 2025 Q2 | 4,437,938 | $18,638,020 | +$2,152,791 | $4.20 | 51 |
| 2025 Q1 | 3,786,321 | $18,062,451 | +$340,769 | $4.77 | 47 |
| 2024 Q4 | 3,859,340 | $14,708,103 | -$4,075,765 | $3.81 | 51 |
| 2024 Q3 | 3,323,629 | $29,812,914 | +$1,425,206 | $8.96 | 50 |
| 2024 Q2 | 3,161,323 | $30,774,875 | -$108,215 | $9.73 | 45 |
| 2024 Q1 | 3,155,622 | $42,757,614 | +$42,755,553 | $13.56 | 40 |